A case of intrahepatic cholangiocarcinoma that was difficult to diagnose prior to surgery: A case report.
cholangiocellular carcinoma
diagnosis
intrahepatic cholangiocarcinoma
Journal
Oncology letters
ISSN: 1792-1074
Titre abrégé: Oncol Lett
Pays: Greece
ID NLM: 101531236
Informations de publication
Date de publication:
Jan 2019
Jan 2019
Historique:
received:
15
05
2018
accepted:
07
09
2018
entrez:
19
1
2019
pubmed:
19
1
2019
medline:
19
1
2019
Statut:
ppublish
Résumé
The present study reports a case of mass-forming intrahepatic cholangiocarcinoma (ICC), which mimicked cholangiocellular carcinoma (CoCC) during imaging and a needle biopsy examination. A 51-year-old female with no relevant medical history was referred to the National Defense Medical College hospital with an intrahepatic tumor. Computed tomography demonstrated non-homogeneous enhancement in the early arterial phase and persistent enhancement in the portal and equilibrium phases, together with notable swelling of the para-aortic lymph nodes. Gadolinium-ethoxybenzyl diethylenetriamine-pentaacetic acid-enhanced magnetic resonance imaging revealed low signal intensity in the hepatobiliary phase. The liver tumor and lymph nodes exhibited increased radiotracer uptake (maximum standardized uptake value=14.0) with positron emission tomography. A histological examination of a percutaneous needle biopsy specimen of the liver tumor indicated a diagnosis of CoCC. The patient underwent left hepatectomy and lymphadenectomy. The surgical specimen contained a poorly differentiated adenocarcinoma with anaplastic changes, which was immunohistochemically positive for epithelial membrane antigen (at the luminal membrane), cytokeratins 7 and 19, and negative for α-fetoprotein, hepatocyte-specific antigen, cluster of differentiation 56 and KIT. Based on these histopathological and immunohistochemical findings, the patient was diagnosed with ICC.
Identifiants
pubmed: 30655835
doi: 10.3892/ol.2018.9666
pii: OL-0-0-9666
pmc: PMC6313065
doi:
Types de publication
Journal Article
Langues
eng
Pagination
823-830Références
Jpn J Clin Oncol. 2003 Jun;33(6):283-7
pubmed: 12913082
J Hepatobiliary Pancreat Surg. 2003;10(4):265-81
pubmed: 14598145
Lancet. 2005 Oct 8;366(9493):1303-14
pubmed: 16214602
J Hepatol. 2006 Dec;45(6):856-67
pubmed: 17030071
J Gastrointest Surg. 2007 Mar;11(3):398-402
pubmed: 17458614
Hepatology. 2008 May;47(5):1544-56
pubmed: 18393293
Surgery. 2009 Apr;145(4):411-6
pubmed: 19303990
J Comput Assist Tomogr. 2009 Sep-Oct;33(5):682-8
pubmed: 19820492
World J Hepatol. 2010 Dec 27;2(12):419-27
pubmed: 21191517
Hepatology. 2012 Jun;55(6):1876-88
pubmed: 22271564
World J Gastrointest Oncol. 2012 May 15;4(5):94-102
pubmed: 22645632
J Hepatobiliary Pancreat Sci. 2014 Mar;21(3):162-8
pubmed: 24027075
J Gastroenterol. 2014 Feb;49(2):165-72
pubmed: 24145988
Ann Surg Oncol. 2014 Jun;21 Suppl 3:S451-8
pubmed: 24633664
J Hepatol. 2015 Jan;62(1):198-207
pubmed: 25220250
World J Gastroenterol. 2014 Nov 21;20(43):15955-64
pubmed: 25473149
Abdom Imaging. 2015 Oct;40(7):2345-54
pubmed: 26088342
Oncotarget. 2015 Jun 20;6(17):14744-53
pubmed: 26142706
PLoS One. 2015 Jul 24;10(7):e0132953
pubmed: 26207380
Int Surg. 2015 Jun;100(6):1111-6
pubmed: 26414834
Cancer. 2016 Jan 1;122(1):61-70
pubmed: 26430782
Dig Dis. 2015 Oct;33(6):765-70
pubmed: 26488173
Cancer. 2016 Mar 1;122(5):758-65
pubmed: 26695839
Clin J Gastroenterol. 2016 Aug;9(4):257-60
pubmed: 27363839
Abdom Radiol (NY). 2017 Mar;42(3):861-869
pubmed: 27747442
Lab Invest. 2016 Dec;96(12):1246-1255
pubmed: 27748735
Curr Gastroenterol Rep. 2017 Jan;19(1):2
pubmed: 28110453
Oncotarget. 2017 Feb 28;8(9):14957-14968
pubmed: 28146430
Onco Targets Ther. 2017 Feb 22;10:1131-1142
pubmed: 28260927
Hepatobiliary Surg Nutr. 2017 Feb;6(1):22-34
pubmed: 28261592
World J Hepatol. 2017 Jun 8;9(16):752-756
pubmed: 28652894
Surg Case Rep. 2017 Sep 15;3(1):103
pubmed: 28916905
Am J Case Rep. 2018 Jan 10;19:35-40
pubmed: 29317591
Ann Gastroenterol. 2018 Jan-Feb;31(1):42-55
pubmed: 29333066